Advertisement
 
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Doctors Use Gene Sequence To Predict Health Risks

April 30, 2010 5:27 am | by Maria Cheng | News | Comments

The next time Stephen Quake is prescribed a drug, he says he won't worry about having a bad reaction. The Stanford University professor will simply consult his genome to see if there are any warning signs in his DNA.

TOPICS:

Microarray Analysis

April 29, 2010 7:29 am | Product Releases | Comments

Illumina, Inc. announced shipment of HiScanSQ, the first instrument to integrate microarray analysis and next-generation sequencing in a modular design that can evolve with changing research needs.

TOPICS:

Site-Specific PEGylation

April 29, 2010 7:24 am | Product Releases | Comments

Almac will be attending BIO 2010, the annual Bio Industry Association convention, at which it will announce the extension of its unique site specific PEGylation technology to cover single domain antibody fragments.

TOPICS:
Advertisement

New Technique Reveals Mechanics Of Blood Cell Membranes

April 29, 2010 7:19 am | News | Comments

Thanks to an interdisciplinary team of researchers, scientists now have a more complete understanding of one of the human body’s most vital structures: the red blood cell.

TOPICS:

Jumping Elements Become Incorporated in the Genome

April 29, 2010 7:13 am | News | Comments

The density of transposable (jumping) elements between sex chromosomes in primates may have important consequences for the studies of human genetic diseases, say Penn State University researchers.

TOPICS:

EyeGate Pharma Collaborating With GSK

April 29, 2010 7:05 am | News | Comments

EyeGate Pharma announces that they have established a research collaboration with GlaxoSmithKline (GSK) to evaluate the delivery of several GSK therapies using the EyeGate II delivery system.

TOPICS:

New Clients Boost Medco Profits

April 29, 2010 6:54 am | News | Comments

Pharmacy benefits manager Medco Health Solutions Inc. said its profit grew 10 percent in the first quarter as it started doing business with several large new clients.

TOPICS:

OvaSave Well-Tolerated In Trial

April 29, 2010 6:38 am | News | Comments

TxCell SA announced positive preliminary results from the ongoing Phase 1/2a clinical trial regarding OvaSave, an investigational new drug, in patients with severe and refractory Crohn’s disease.

TOPICS:
Advertisement

Vitamin E Helps in Liver Disease

April 29, 2010 6:29 am | by Alicia Chang | News | Comments

People with a common, obesity-related liver disease that has no known treatment got a surprising benefit from vitamin E pills, researchers reported.

TOPICS:

Sanofi-Aventis Profits Rise 8.6% in First Quarter

April 29, 2010 6:23 am | by Emma Vandore | News | Comments

Sanofi-Aventis reported an 8.6 percent increase in first quarter net profit thanks to its swine flu vaccine and strong sales of diabetes treatment Lantus.

TOPICS:

AstraZeneca Q1 Profit Up 29%

April 29, 2010 6:16 am | News | Comments

Anglo-Swiss pharmaceutical company AstraZeneca PLC reported that first-quarter profit rose by 29 percent, but cautioned that comparisons will be tougher in the second half of the year when a key patent expires.

TOPICS:

Integrated Response Technology

April 29, 2010 6:11 am | Product Releases | Comments

endpoint Clinical announced that PULSE, a fully configurable platform that allows users to design and deploy clinical trial Integrated Response Technology (IRT) systems, saves 40 percent on the development time of clinical trials.

TOPICS:

TrialTrove Reaches Landmark 100k Trial

April 29, 2010 6:06 am | News | Comments

Citeline’s TrialTrove, a leading global pharmaceutical intelligence service, now tracks more than 100,000 clinical trials around the world, making it among the most comprehensive source of clinical trial information available.

TOPICS:

Cardiac Safety Software

April 29, 2010 5:57 am | Product Releases | Comments

ERT, a leading provider of centralized services to the biopharmaceutical, medical device and related industries, announced the launch of Centralized Cardiac Safety 2.0, a portfolio of new solutions that enable a significant new approach to cardiac safety in clinical trials.

TOPICS:

Trial Reporting

April 29, 2010 5:49 am | Product Releases | Comments

Almac Clinical Technologies announced the release of a new reporting solution for its IXRS integrated phone and web response technology, Almac Interactive Reporting.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading